Henry Schein Gestione

Gestione criteri di controllo 2/4

Henry Schein Il CEO è Stan Bergman, nominato in Jan1989, e ha un mandato di 35.83 anni. la retribuzione annua totale è $ 10.01M, composta da 16.2% di stipendio e 83.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.6% delle azioni della società, per un valore di $ 57.87M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 8.8 anni e 12.3 anni.

Informazioni chiave

Stan Bergman

Amministratore delegato

US$10.0m

Compenso totale

Percentuale dello stipendio del CEO	16.2%
Mandato del CEO	35.8yrs
Proprietà del CEO	0.6%
Durata media del management	8.8yrs
Durata media del Consiglio di amministrazione	12.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Stan Bergman rispetto agli utili di Henry Schein?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 28 2024	n/a	n/a	US$314m
Jun 29 2024	n/a	n/a	US$352m
Mar 30 2024	n/a	n/a	US$388m
Dec 30 2023	US$10m	US$2m	US$416m
Sep 30 2023	n/a	n/a	US$445m
Jul 01 2023	n/a	n/a	US$458m
Apr 01 2023	n/a	n/a	US$478m
Dec 31 2022	US$8m	US$2m	US$538m
Sep 24 2022	n/a	n/a	US$638m
Jun 25 2022	n/a	n/a	US$650m
Mar 26 2022	n/a	n/a	US$646m
Dec 25 2021	US$11m	US$2m	US$631m
Sep 25 2021	n/a	n/a	US$626m
Jun 26 2021	n/a	n/a	US$606m
Mar 27 2021	n/a	n/a	US$438m
Dec 26 2020	US$6m	US$751k	US$403m
Sep 26 2020	n/a	n/a	US$591m
Jun 27 2020	n/a	n/a	US$585m
Mar 28 2020	n/a	n/a	US$713m
Dec 28 2019	US$14m	US$1m	US$701m
Sep 28 2019	n/a	n/a	US$488m
Jun 29 2019	n/a	n/a	US$444m
Mar 30 2019	n/a	n/a	US$438m
Dec 29 2018	n/a	n/a	US$431m
Sep 29 2018	n/a	n/a	US$304m
Jun 30 2018	n/a	n/a	US$352m
Mar 31 2018	n/a	n/a	US$377m

Compensazione vs Mercato: La retribuzione totale di Stan ($USD 10.01M ) è superiore alla media delle aziende di dimensioni simili nel mercato UK ($USD 3.22M ).

Compensazione vs guadagni: La retribuzione di Stan è aumentata di oltre il 20%, mentre gli utili aziendali sono diminuiti di oltre il 20% nell'ultimo anno.

AMMINISTRATORE DELEGATO

Stan Bergman (74 yo)

35.8yrs

Mandato

US$10,005,729

Compensazione

Mr. Stanley M. Bergman, also known as Stan, has been the Chief Executive Officer and Executive Chairman of Henry Schein, Inc. since 1989 and has been its Executive Director since 1982. Mr. Bergman served a...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Stanley Bergman	Executive Chairman & CEO	35.8yrs	US$10.01m	0.60% $ 57.9m
James Breslawski	President	19.5yrs	US$2.69m	0.11% $ 11.0m
Ronald South	Senior VP & CFO	2.6yrs	US$2.35m	0.0080% $ 763.6k
Michael Ettinger	Executive VP & COO	2.3yrs	US$2.97m	0.071% $ 6.8m
Mark Mlotek	Executive VP	12.8yrs	US$3.22m	0.075% $ 7.2m
Olga Timoshkina	VP of Corporate Finance	3.2yrs	Nessun dato	Nessun dato
Christopher Pendergast	Senior VP & CTO	6.6yrs	Nessun dato	Nessun dato
Graham Stanley	VP of Investor Relations & Strategic Finance Project Officer	no data	Nessun dato	Nessun dato
Walter Siegel	Senior VP & Chief Legal Officer	11.1yrs	Nessun dato	0.032% $ 3.0m
Ann Gothard	Vice President of Global Corporate Media Relations	no data	Nessun dato	Nessun dato
Christine Sheehy	Senior VP & Chief Human Resources Officer	less than a year	Nessun dato	Nessun dato
Gerard Meuchner	Chief Global Communications Officer & VP	12.8yrs	Nessun dato	Nessun dato

8.8yrs

Durata media

63.5yo

Età media

Gestione esperta: Il team dirigenziale di 0L3C è esperto e expertise (durata media dell'incarico 8.8 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Stanley Bergman	Executive Chairman & CEO	42.8yrs	US$10.01m	0.60% $ 57.9m
Mark Mlotek	Executive VP	29.2yrs	US$3.22m	0.075% $ 7.2m
Philip Laskawy	Independent Lead Director	22.8yrs	US$335.40k	0.029% $ 2.8m
Joseph Herring	Independent Director	8.5yrs	US$313.00k	0.018% $ 1.7m
Louis Sullivan	Chairman of Medical Advisory Board	18.3yrs	US$262.90k	Nessun dato
Norman Matthews	Member of Medical Advisory Board	no data	US$265.15k	Nessun dato
Bradley Sheares	Independent Director	14.8yrs	US$304.20k	0.0027% $ 256.8k
Carol Raphael	Independent Director	12.3yrs	US$282.60k	0.023% $ 2.3m
Kurt Kuehn	Independent Director	8.5yrs	US$316.40k	0.0014% $ 135.1k
Deborah Derby	Independent Director	3.8yrs	US$304.80k	0.00061% $ 58.4k
Mohamad Ali	Independent Director	3.8yrs	US$271.60k	0.0061% $ 585.4k
Anne Margulies	Independent Director	6.4yrs	US$291.40k	0.016% $ 1.5m

12.3yrs

Durata media

69yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 0L3C è composto da personale esperto e esperto (durata media dell'incarico 12.3 anni).

Henry Schein Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Insider recently sold US$1.5m worth of stock

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Insider recently sold US$478k worth of stock

Henry Schein Appoints Carole T. Faig as New Independent Director

Insider recently sold US$835k worth of stock

Recent updates

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire Acentus.

Ananym Capital Management Pushes for Changes at Henry Schein

New minor risk - Earnings quality

Third quarter 2024 earnings released: EPS: US$0.79 (vs US$1.05 in 3Q 2023)

Henry Schein, Inc. Updates Earnings Guidance for the Full Year 2024

Henry Schein, Inc. to Report Q3, 2024 Results on Nov 05, 2024

Henry Schein, Inc.(NasdaqGS:HSIC) dropped from FTSE All-World Index (USD)

Insider recently sold US$1.5m worth of stock

Second quarter 2024 earnings released: EPS: US$0.81 (vs US$1.07 in 2Q 2023)

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Henry Schein, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

First quarter 2024 earnings released: EPS: US$0.72 (vs US$0.92 in 1Q 2023)

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Insider recently sold US$478k worth of stock

Full year 2023 earnings released: EPS: US$3.19 (vs US$3.95 in FY 2022)

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: US$1.07 (vs US$1.17 in 2Q 2022)

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

Insider recently sold US$835k worth of stock

Executive VP recently sold US$1.9m worth of stock

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings released: EPS: US$0.92 (vs US$1.32 in 1Q 2022)

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Independent Director recently sold US$148k worth of stock

Independent Lead Director recently sold US$504k worth of stock

Now 20% undervalued after recent price drop

Independent Director recently sold US$923k worth of stock

Full year 2022 earnings released: EPS: US$3.95 (vs US$4.51 in FY 2021)

Henry Schein, Inc. Reports Impairment Charge on Intangible Assets for the Fourth Quarter Ended December 31, 2022

Henry Schein, Inc. (NasdaqGS:HSIC) announces an Equity Buyback for $400 million worth of its shares.

Henry Schein, Inc. to Report Q4, 2022 Results on Feb 16, 2023

Insider recently sold US$1.2m worth of stock

Henry Schein, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Henry Schein, Inc. Announces its Lineup of Products and Solutions At the American Association of Oral and Maxillofacial Surgeons (AAOMS) Annual Conference in New Orleans, La. from September 12 Through September 17

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Midway Dental Supply, Inc.

Henry Schein, Inc. Announces the Passing of Board Member E. Dianne Rekow

Second quarter 2022 earnings released: EPS: US$1.17 (vs US$1.11 in 2Q 2021)

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year 2022

Henry Schein, Inc. Appoints Mark Hillebrandt as Chief Digital Revenue Officer

Henry Schein, Inc. to Report Q2, 2022 Results on Aug 02, 2022

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Condor Dental Research Company SA from MCCB Holding Sarl.

Henry Schein, Inc.(NasdaqGS:HSIC) dropped from Russell 1000 Dynamic Index

Henry Schein, Inc. (NasdaqGS:HSIC) entered into a definitive agreement to acquire Condor Dental Research Company SA from MCCB Holding Sarl.

Insider recently sold US$982k worth of stock

Henry Schein, Inc. Appoints Dirk Benson as Chief Commercial Officer of North America Distribution Group

Henry Schein, Inc. Provides Earnings Guidance for the Year 2022

First quarter 2022 earnings released: EPS: US$1.32 (vs US$1.17 in 1Q 2021)

Henry Schein, Inc. to Report Q1, 2022 Results on May 03, 2022

Henry Schein Inc. Announces Executive Changes, Effective from July 1, 2022

Henry Schein Promotes Jennifer Ferrero to Corporate Secretary, Effective July 1, 2022

Executive VP recently sold US$2.0m worth of stock

Henry Schein to Showcase A Wide Portfolio of Products, Services, and Solutions During the Chicago Midwinter Dental Meeting